2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
- PMID: 33332149
- DOI: 10.1161/CIR.0000000000000932
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Erratum in
-
Correction to: 2020 ACC/AHA Guideline on the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.Circulation. 2021 Feb 2;143(5):e228. doi: 10.1161/CIR.0000000000000960. Epub 2021 Feb 1. Circulation. 2021. PMID: 33523732 No abstract available.
-
Correction to: 2020 ACC/AHA Guideline on the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.Circulation. 2021 Mar 9;143(10):e784. doi: 10.1161/CIR.0000000000000966. Epub 2021 Mar 8. Circulation. 2021. PMID: 33683951 No abstract available.
Abstract
Aim: This executive summary of the valvular heart disease guideline provides recommendations for clinicians to diagnose and manage valvular heart disease as well as supporting documentation to encourage their use.
Methods: A comprehensive literature search was conducted from January 1, 2010, to March 1, 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, Cochrane, Agency for Healthcare Research and Quality Reports, and other selected database relevant to this guideline. Structure: Many recommendations from the earlier valvular heart disease guidelines have been updated with new evidence and provides newer options for diagnosis and treatment of valvular heart disease. This summary includes only the recommendations from the full guideline which focus on diagnostic work-up, the timing and choice of surgical and catheter interventions, and recommendations for medical therapy. The reader is referred to the full guideline for graphical flow charts, text, and tables with additional details about the rationale for and implementation of each recommendation, and the evidence tables detailing the data considered in developing these guidelines.
Keywords: AHA Scientific Statements; anscatheter aortic valve replacement or implantation; anticoagulation therapy; aortic regurgitation; aortic stenosis; bicuspid aortic valve; cardiac surgery; infective endocarditis; mitral regurgitation; mitral stenosis; mitral transcatheter edge-to-edge repair; prosthetic valve; pulmonic regurgitation; pulmonic stenosis; tricuspid regurgitation; tricuspid stenosis; valvular heart disease.
Similar articles
-
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.Circulation. 2022 Jan 18;145(3):e4-e17. doi: 10.1161/CIR.0000000000001039. Epub 2021 Dec 9. Circulation. 2022. PMID: 34882436 Review.
-
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.J Am Coll Cardiol. 2021 Feb 2;77(4):450-500. doi: 10.1016/j.jacc.2020.11.035. Epub 2020 Dec 17. J Am Coll Cardiol. 2021. PMID: 33342587
-
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.J Am Coll Cardiol. 2021 Feb 2;77(4):e25-e197. doi: 10.1016/j.jacc.2020.11.018. Epub 2020 Dec 17. J Am Coll Cardiol. 2021. PMID: 33342586 No abstract available.
-
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.Circulation. 2021 Feb 2;143(5):e72-e227. doi: 10.1161/CIR.0000000000000923. Epub 2020 Dec 17. Circulation. 2021. PMID: 33332150 No abstract available.
-
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.Circulation. 2014 Jun 10;129(23):2440-92. doi: 10.1161/CIR.0000000000000029. Epub 2014 Mar 3. Circulation. 2014. PMID: 24589852 No abstract available.
Cited by
-
Identification of Diagnostic Genes of Aortic Stenosis That Progresses from Aortic Valve Sclerosis.J Inflamm Res. 2024 May 28;17:3459-3473. doi: 10.2147/JIR.S453100. eCollection 2024. J Inflamm Res. 2024. PMID: 38828052 Free PMC article.
-
Outcomes after surgery for infective endocarditis.Indian J Thorac Cardiovasc Surg. 2024 May;40(Suppl 1):126-137. doi: 10.1007/s12055-023-01647-9. Epub 2023 Dec 30. Indian J Thorac Cardiovasc Surg. 2024. PMID: 38827557 Review.
-
Long-term prosthetic-associated subclinical thrombotic events evaluation by cardiac CTA after transcatheter aortic valve implantation: incidence and outcomes.Insights Imaging. 2024 May 30;15(1):125. doi: 10.1186/s13244-024-01681-0. Insights Imaging. 2024. PMID: 38816554 Free PMC article.
-
Infection of Transcatheter Valvular Devices.Curr Cardiol Rep. 2024 May 28. doi: 10.1007/s11886-024-02076-9. Online ahead of print. Curr Cardiol Rep. 2024. PMID: 38806975 Review.
-
Evaluation and Management of Mechanical Heart Valve Dysfunction and Thrombosis.Curr Cardiol Rep. 2024 May 24. doi: 10.1007/s11886-024-02074-x. Online ahead of print. Curr Cardiol Rep. 2024. PMID: 38789693 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical